Dr. Laird is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3399 PGA Blvd
Suite 350
Palm Beach Gardens, FL 33410Phone+1 561-624-0099Fax+1 561-624-7373
Summary
- Philip Laird M.D. is a native Floridian who graduated with Honors from University of Florida. While at Florida, he was a member of the varsity Track & Field and Cross Country teams. He is a recipient of the College of Health and Human Performance Outstanding Young Alumnus Award.
Dr. Laird then attended medical school at Mayo Clinic in Rochester, Minnesota and was awarded the Dean's Award as well as a National Eye Institute research award. He then completed a General Surgery internship at the Mayo Clinic in Jacksonville, Florida.
Dr. Laird attained his formal Ophthalmology training at Emory University in Atlanta, Georgia. After completing residency, he stayed at Emory for a two-year fellowship in Vitreoretinal Disease and Surgery.
Dr. Laird has published numerous manuscripts and book chapters in the field of Ophthalmology and Retina and has presented his research at national forums. He is an investigator in multiple clinical trials and currently serves as a reviewer for the American Journal of Ophthalmology.
Dr. Laird is a Board-Certified Ophthalmologist specializing in all aspects of Vitreoretinal disease and surgery. He is an active member of the American Society of Retina Specialists and the American Academy of Ophthalmology.
Outside of medicine, Dr. Laird lives in Jupiter and is happily married with two children. He enjoys distance running, traveling, and spending time with his family.
Education & Training
- Emory University School of MedicineFellowship, Surgical Retina and Vitreous, 2012 - 2014
- Emory University School of MedicineResidency, Ophthalmology, 2009 - 2012
- Mayo Clinic College of Medicine and ScienceInternship, Transitional Year, 2008 - 2009
- Mayo Clinic College of MedicineClass of 2008
Certifications & Licensure
- FL State Medical License 2014 - 2026
- GA State Medical License 2011 - 2014
- American Board of Ophthalmology Ophthalmology
Clinical Trials
- A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy Start of enrollment: 2013 Aug 01
- A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration Start of enrollment: 2014 Sep 18
- An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy Start of enrollment: 2012 May 29
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsToxoplasmosis chorioretinitis mimicking acute retinal necrosis associated with local corticosteroidJason N. Crosson, Sanjana Kuthyar, Jessica G. Shantha, Matthew R. Debiec, Philip W. Laird
International Journal of Retina and Vitreous. 2020-06-03 - 23 citationsExacerbation of Susac syndrome retinopathy by interferon Beta-1a.Philip W. Laird, Nancy J. Newman, Steven Yeh
Archives of Ophthalmology. 2012-06-01 - 66 citationsVogt-Koyanagi-Harada-like syndrome after CTLA-4 inhibition with ipilimumab for metastatic melanoma.Jason N. Crosson, Philip W. Laird, Matthew R. Debiec, Chris S. Bergstrom, David H. Lawson
Journal of Immunotherapy. 2015-02-01
Research History
- Clinical InvestigatorDr. Laird participates in clinical research and is an investigator in multiple national clinical trials.2012 - Present
External Links
- Retina Care Specialistshttp://www.retinacarespecialists.com
- Facebook Pagehttps://www.facebook.com/retinacarespecialists
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: